Olmesact 10 mg Tablet (Olmesartan Medoxomil)
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
HanKook Daiichi Sankyo Co., Ltd.
MFDS item code 201305056 · Approved 2013.02.15
This product's status changed to Approval withdrawn on 2025.12.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension
Essential hypertension is an important condition for maintaining blood pressure within the normal range to reduce the risk of cardiovascular diseases. This medication helps lower blood pressure and relieve the burden on the heart and blood vessels, improving health. By maintaining consistent usage, it can also contribute to the prevention of complications. Thus, it is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, administered regardless of meals. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time every day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while carefully monitoring their condition. <Elderly> No dose adjustment is required when administering this drug to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg once daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients.
<Pediatric patients> Safety and efficacy have not been established in pediatric patients.
This drug may cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be immediately discontinued upon confirmation of pregnancy. It should not be used by patients who are allergic to any of its components, are pregnant or breastfeeding, are undergoing renal dialysis, have severe liver disease, have bile duct obstruction, or have certain genetic lactose intolerance. Patients with low blood volume or low salt, those with reduced kidney function, kidney transplant recipients, patients with renovascular hypertension, those at risk for hyperkalemia, patients with aortic or mitral stenosis, and those with primary aldosteronism should use this drug with special caution. This medication may cause dizziness; hence, it is advisable to avoid hazardous activities such as driving or operating machinery. Patients with hypertension may commonly experience mild side effects like dizziness, and there have been rare reports of chest pain, peripheral edema, abdominal pain, headache, rash, etc. If symptoms of gastrointestinal issues, such as chronic diarrhea, appear, the medication should be discontinued immediately, and a specialist should be consulted. Caution is needed if used in combination with potassium-sparing diuretics or potassium supplements as it can increase blood potassium levels, and it can enhance the blood pressure-lowering effect when combined with other antihypertensives. Lithium preparations should not be used concurrently as they may increase lithium levels and cause toxicity. Kidney function should be periodically monitored when used in conjunction with non-steroidal anti-inflammatory drugs as it may worsen renal function. Use during pregnancy poses significant risks to fetal health, and it is also recommended to stop breastfeeding or discontinue use during lactation, as this drug may be transmitted through breast milk. Safety in children has not been established, so it is not advisable to use in pediatric patients. Elderly patients may have increased drug concentrations in the body, so caution is necessary when administering. Overdose may result in hypotension, palpitations, bradycardia, etc.; therefore, if any symptoms occur, it is essential to inform healthcare professionals immediately for appropriate treatment.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent air or moisture ingress. It is recommended to maintain the storage temperature between 1°C and 25°C at room temperature.
White round film-coated tablet
28 tablets (14 tablets/PTP X 2)/ carton
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
HanKook Daiichi Sankyo Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.